Detailed Information

Cited 6 time in webofscience Cited 2 time in scopus
Metadata Downloads

All-in-one microfluidic design to integrate vascularized tumor spheroid into high-throughput platform

Authors
Kim, Y[Kim, Youngtaek]Ko, J[Ko, Jihoon]Shin, N[Shin, Nari]Park, S[Park, Seonghyuk]Lee, SR[Lee, Seung-Ryeol]Kim, S[Kim, Suryong]Song, J[Song, Jiyoung]Lee, S[Lee, Seokjun]Kang, KS[Kang, Kyung-Sun]Lee, J[Lee, Jeeyun]Jeon, NL[Jeon, Noo Li]
Issue Date
Dec-2022
Publisher
WILEY
Keywords
all-in-one; high-throughput experimentation; microfluidics; organ-on-a-chip; patient-derived cancer cells (PDCs); tumor microenvironment (TME); vascularized tumor spheroid
Citation
BIOTECHNOLOGY AND BIOENGINEERING, v.119, no.12, pp.3678 - 3693
Indexed
SCIE
SCOPUS
Journal Title
BIOTECHNOLOGY AND BIOENGINEERING
Volume
119
Number
12
Start Page
3678
End Page
3693
URI
https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/100010
DOI
10.1002/bit.28221
ISSN
0006-3592
Abstract
The development of a scalable and highly reproducible in vitro tumor microenvironment (TME) platform still sheds light on new insights into cancer metastasis mechanisms and anticancer therapeutic strategies. Here, we present an all-in-one injection molded plastic array three-dimensional culture platform (All-in-One-IMPACT) that integrates vascularized tumor spheroids for highly reproducible, high-throughput experimentation. This device allows the formation of self-assembled cell spheroids on a chip by applying the hanging drop method to the cell culture channel. Then, when the hydrogel containing endothelial cells and fibroblasts is injected, the spheroid inside the droplet can be patterned together in three dimensions along the culture channel. In just two steps above, we can build a vascularized TME within a defined area. This process does not require specialized user skill and minimizes error-inducing steps, enabling both reproducibility and high throughput of the experiment. We have successfully demonstrated the process, from spheroid formation to tumor vascularization, using patient-derived cancer cells (PDCs) as well as various cancer cell lines. Furthermore, we performed combination therapies with Taxol (paclitaxel) and Avastin (bevacizumab), which are used in standard care for metastatic cancer. The All-in-One IMPACT is a powerful tool for establishing various anticancer treatment strategies through the development of a complex TME for use in high-throughput experiments.
Files in This Item
There are no files associated with this item.
Appears in
Collections
Medicine > Department of Medicine > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher LEE, JEE YUN photo

LEE, JEE YUN
Medicine (Medicine)
Read more

Altmetrics

Total Views & Downloads

BROWSE